newsfilter
← Latest News
Business Wire·

Virios Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update

- Enrollment Completed in FORTRESS Study with Top Line Data Expected in September 2022 - - Conference Call Today at 8:30 a.m. ET - Virios Therapeutics, Inc. (NASDAQ:VIRI), a development-stage biotechnology company focused on advancing novel, combi